Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Biochim Biophys Acta. 2015 Jul 22;1850(11):2368–2376. doi: 10.1016/j.bbagen.2015.07.005

Alcohol binding in the C1 (C1A + C1B) domain of protein kinase C epsilon

Satyabrata Pany 1, Joydip Das 1,*
PMCID: PMC4586410  NIHMSID: NIHMS710303  PMID: 26210390

Abstract

Background

Alcohol regulates the expression and function of protein kinase C epsilon (PKCε). In a previous study we identified an alcohol binding site in the C1B, one of the twin C1 subdomains of PKCε.

Methods

In this study, we investigated alcohol binding in the entire C1 domain (combined C1A and C1B) of PKCε. Fluorescent phorbol ester, SAPD and fluorescent diacylglycerol (DAG) analog, dansyl-DAG were used to study the effect of ethanol, butanol, and octanol on the ligand binding using fluorescence resonance energy transfer (FRET). To identify alcohol binding site(s), PKCεC1 was photolabeled with 3-azibutanol and 3-azioctanol, and analyzed by mass spectrometry. The effects of alcohols and the azialcohols on PKCε were studied in NG108-15 cells.

Results

In the presence of alcohol, SAPD and dansyl-DAG showed different extent of FRET, indicating differential effects of alcohol on the C1A and C1B subdomains. Effects of alcohols and azialcohols on PKCε in NG108-15 cells were comparable. Azialcohols labeled Tyr-176 of C1A and Tyr-250 of C1B. Inspection of the model structure of PKCεC1 reveals that these residues are 40 Å apart from each other indicating that these residues form two different alcohol binding sites.

Conclusions

The present results provide evidence for the presence of multiple alcohol-binding sites on PKCε and underscore the importance of targeting this PKC isoform in developing alcohol antagonists.

Keywords: protein kinase Cε (PKCε), alcohol-binding site, alcoholism, fluorescence resonance energy transfer (FRET), mass spectrometry (MS), photoaffinity

Graphical abstract

graphic file with name nihms-710303-f0001.jpg

1. INTRODUCTION

Protein kinase Cε (PKCε) [1] is a member of the serine/threonine kinase superfamily that has been implicated in the neurobiology of drug abuse and alcohol addiction [2-5]. An understanding of the molecular mechanisms underlying the alcohol and PKCε interaction and its functional consequence is crucial for the development of alcohol antagonists.

The PKC superfamily plays a central role in signal transduction, regulating diverse cellular functions by phosphorylation of target proteins [6-8]. PKCs modulate both pre- and postsynaptic neuronal functions, such as synthesis and release of neurotransmitters, regulation of receptors and ion channels, neuronal excitability, and gene expression in the brain [9-11]. The PKC superfamily can be separated into three major categories, the conventional (α, βI, βII, γ), novel (δ, ε, θ, η), and atypical (ζ, Ι) isoforms. The conventional and novel PKCs have four domains, termed C1 through C4. The C1 domain consists of a tandem repeat of highly conserved cysteine–rich zinc finger subdomains, C1A and C1B, which bind diacylglycerol (DAG)/phorbol ester (Fig.1). These subdomains differ in their binding affinities for phorbol ester and DAG [12-15]. In contrast, the atypical PKCs are non-responsive to DAG/phorbol ester. There is high homology within domains among different members of the superfamily but the novel kinases differ in having the C2 domain at the N-terminal. Whereas the conventional PKCs associate with membranes in a calcium-dependent manner, the novel PKCs are calcium-independent. PKCs are translocated from the cytosol to the plasma membrane upon activation, by binding to isoform-specific RACK proteins [16, 17]. The cellular activation causes translocation of PKC to different subcellular locations in an activator-dependent manner [18]. Each domain plays a distinct role in the activation and subcellular translocation of PKC.

Figure 1.

Figure 1

(A) Schematic representation of the domains of protein kinase Cε: the C1 regulatory domain binds to lipids, diacylglycerol, and phorbol esters; the C2 regulatory domain binds to anionic lipids but does not bind to Ca2+; C3 is the ATP-binding domain and C4 the catalytic domain. PS denotes the pseudo-substrate-binding domain. (B) Amino acid sequence of PKCεC1. PKCεC1 with 123 amino acid residues (C1A, 170-220 and C1B, 242-292) was used in the present study. Underlined extra residues were included for cloning and purification purposes.

Behavioral tests reveal that PKCε null mice have drastically decreased alcohol consumption. PKCε null mouse consumed approximately 75% less alcohol and showed reduced ethanol preference in a two-bottle choice paradigm [19] and self-administered about 50% less ethanol in an operant self-administration paradigm compared to the wild-type mice [20]. These findings are associated with enhanced sensitivity to the acute hypnotic effects of ethanol. Effects of ethanol are isoform specific, as PKCγ null mice consumed more alcohol compared to the wild-type mice in the two bottle choice paradigm [21] and displayed reduced sensitivity to ethanol [22]. Furthermore, knock-down of PKCε in different brain regions reduced ethanol intake [23]. Rescuing PKCε expression in different brain regions restores ethanol intake and hypnotic sensitivity to levels observed in wild-type mice [24].

Chronic alcohol exposure up-regulates PKCε expression in the dorsal root ganglion (DRG) neuron [25, 26]. Ethanol stimulates expression and translocation of PKCε in PC12 cells [27, 28]. The prominent effect of ethanol on PKCε was evident in the NG108-15 cell system, in which ethanol altered translocation of PKCε either directly [29, 30] or synergistically with dopamine [31].

In order to identify the site(s) of alcohol action on PKCε, we previously studied the alcohol binding site in its C1B subdomain [32]. We found that ethanol inhibited DAG-stimulated PKCε activity with an EC50 of ~43 mM which is higher than the social drinking range (10-20 mM) but below the range of of lethal blood alcohol concentration (50-110 mM)[33]. We also identified His-248 and Tyr-250 as the alcohol binding sites in the C1B subdomain using photolabeling and mass spectrometry [32].

In continuation of our studies on characterizing the alcohol binding site(s) in PKCε, here we used the PKCεC1 (combined C1A and C1B) to study alcohol binding. The effect of ethanol, butanol, and octanol on the FRET between the C1 domain and SAPD and dansyl-DAG (Fig.2) was determined. Two alcohol binding residues Tyr-176 in C1A and Tyr-250 were identified by photolabeling and mass spectrometry.

Figure 2.

Figure 2

SAPD (left) and dansyl-DAG (right).

The diazirine analog of ethanol, aziethanol has never been synthesized because of the inherent instability associated with the molecule. Therefore, the azialcohols, such as, 3-azibutanol and 3-azioctanol have been used extensively for studying the alcohol binding sites in enzymes and receptors [34]. However, neither the effect of these azialcohols nor the effects of the parent alcohols, butanol and octanol on PKCε in a cellular environment were previously examined. Studying the effect of these alcohols on the expression/activity of PKCε would therefore add the biological significance of the present binding studies. We found that in NG108-15 cells ethanol and butanol increased the expression of PKCε in cytosol, while octanol decreased the expression.

2. EXPERIMENTAL

2.1. Materials

E.coli BL21 (DE3) competent cells were obtained from Stratagene, La Jolla, CA, USA. pET21d+ was purchased from Novagen, USA. SAPD (sapintoxin D) was purchased from LC laboratories, Woburn, MA, USA. Glutathione–Sepharose 4B was from GE Healthcare Life Sciences, Piscataway, NJ, USA. Dansyl-DAG was kindly provided by Dr. M. D. Best of the University of Tennessee. 3-Azioctanol [35] and 3-azibutanol[36] were synthesized as described previously. Aldrithiol-4 (4,4′-dithiodipyridine) was purchased from Sigma chemicals Co., St. Louis, MO, USA. LB (Luria–Bertani) broth medium, TB (terrific broth) medium, and SOC (super optimal culture) were obtained from Invitrogen, Carlsbad, CA, USA. Protein estimations were carried out using the Bradford protein estimation kit from Bio-Rad, Hercules, CA, USA. Primary (PKCε and β-actin) and secondary (anti-rabbit HPR) antibodies were from Cell Signaling Technology, Danvers, USA. All the other reagents were from Sigma and of highest purity available.

2.2. Cell culture, Cell fractionation and Western blot analysis

NG108-15 cells were maintained in DME medium supplemented with 25 mM glucose, 44 mM NaHCO3, 10% fetal bovine serum (FBS), and 100 unit/ml antibiotics in humidified atmosphere (37 °C, 5% CO2). Prior to the alcohol treatment, cells were starved in the media devoid of FBS and antibiotics for 12 h at 60–70% confluency. This was done to avoid possible variations induced by serum factors and their interaction with alcohol [37, 38]. Cells were treated with various concentrations of alcohol (ethanol, butanol, octanol, azibutanol, or azioctanol) for 24 h. For measuring the effect of alcohol on the PKCε expression in total cell lysate, alcohol-treated cells were washed PBS and lysed with cell lysis buffer (Cell Signaling, Danvers, MA). Cells were then sonicated briefly (20 s, 5 s pulse, 5 s break, 10% amplitude) and centrifuged at 10,000 rpm (Sorvall Legend Micro 17) for 10 min at 4 °C. Cell lysate (40μg/lane) was subjected to SDS-PAGE and immunoblot.

Membrane fractionations were done according to the protocol described earlier [30]. Cell lysis was carried out in lysis buffer (20 mM Tris, protease inhibitor, pH 7.4) with brief sonications (4 times, 5 seconds, and 10% amplitude). Cell debris was removed by centrifuging the sample at 3500 rpm (Sorvall Legend Micro 17) for 10 min at 37 °C. Cell lysate (200 μg protein/100 μl) was then centrifuged at 40,000 rpm for 2 h at 4 °C using Beckman TLA 120.2 rotor to separate out the cytosolic fraction. The pellet (membrane fraction) was incubated in lysis buffer (100 μl) containing 1% Triton X-100 for 1 h in ice and was sonicated again for homogenization. Cytosolic (40 μg) and membrane fraction (40 μg) were subjected to SDS-PAGE and immunoblot. Proteins were transferred to nitrocellulose membrane and the membrane was incubated successively with 5% BSA in TBST buffer (50 mM Tris, pH 7.5, containing 0.15 M NaCl and 0.1 % Tween-20) at room temperature for 1 h. The blots were probed with PKCε (1:1000 dilution) and β-actin antibody (1:5000 dilution). The blot was further probed with anti-rabbit HRP (1:5000 dilution). The immunoreactive bands were visualized using ECL (enhanced chemiluminescence) reagent (Pierce, Rockford, IL) and quantitated using Alpha Imager Gel Documentation system (Alpha Innotec, Santa Clara, CA).

2.3. Expression and purification of PKCεC1

The PKCεC1 (residues 170-292 in the full-length protein) was subcloned into pET28a+ vector with the carboxy terminus having a His6 tag [39]. The recombinant plasmid was transformed in E. coli BL21 (DE3) for expression and purification of the protein. A single colony from a freshly transformed plate was inoculated in 10 ml LB medium with ampicillin (100μg/ml) and the culture was grown overnight at 37 °C. 5 ml of this inoculum was added to 1 liter TB-ampicillin media and allowed to grow until the absorbance at 600 nm reached 0.8. IPTG (0.5 mM) was then added to induce protein expression and cultures were allowed to grow for an additional 4 h at 37 °C. The bacterial cells were harvested and suspended in 20 ml of Buffer A (50 mM Tris, pH 10, 100 mM NaCl, 50 μM ZnSO4, 8 M Urea) and kept at room temperature for 1 h. The cells were then sonicated 20 times for 5 s at 30% amplitude using a Branson digital sonifier model 250 and the insoluble cellular debris was removed by centrifugation (17,000g for 30 min at 22 °C). The supernatant constituted the denaturated protein fraction which was incubated with 1 ml bed volume of Ni-NTA agarose column. The column was washed with Buffer B (Buffer A plus 10 mM imidazole) until maximum amounts of impurity were removed. Protein was eluted using elution buffer (Buffer A plus 500 mM L-arginine, 10 mM cysteine protease inhibitor and 300 mM imidazole). Protein refolding was initiated by dilution of the denatured protein suspension up to 0.5 M urea with refolding buffer (Buffer A with 250 mM L-arginine, 10 mM cysteine protease inhibitor, and without 8 M urea). Refolded protein was concentrated and dialyzed with above refolding buffer. Purity of the protein was checked by SDS–PAGE (15%) using Coomassie blue staining. Molecular weight of the purified protein was verified by MALDI-TOF mass spectrometry (Applied Biosciences Voyager System 4160). Protein (10nmole/μl) was mixed properly in 1: 10 ratio with saturated solution (50:50 water/aceonitrile with 0.1% trifluoroacetic acid) of α-cyano-4-hydroxycinnamic acid followed by ZipTip (Milipore Corp. GA) purification. The functionality of the refolded protein was examined by intrinsic fluorescence and ligand binding assays.

2.4. Reaction of PKCεC1 with aldrithiol-4 (4,4′-dithiodipyridine) (PDS)

PKCεC1 contains 13 cysteine residues. The reactivity of these cysteine residues with water soluble thiol reagent could be an indicator of the number of cysteine residues exposed to water or buried inside the protein. To study this, PDS was used as the thiol reactive agent [40]. The assay mixture (500 μl) contained 5 μM PKCεC1 and 25 μM of aldrithiol-4 in 5 mM phosphate buffer, pH 6. Reaction of cysteine with PDS generates dithiopyridine, which has the absorption maximum at 323 nm. Right after the addition of PDS to the protein, absorbance at 323 nm was measured at regular time intervals. Background absorption at 323 nm was recorded by using the same concentration of PDS as a reference. Stoichiometry of labeling was determined using the extinction co-efficient value of 19,000 M−1cm−1 for dithiopyridone [41]. The denatured protein (in 5 mM phosphate buffer, pH 6 and 8M urea) was also labeled with PDS for comparing with the refolded PKCεC1.

2.5. Fluorescence measurements

Fluorescence measurements were carried out using PTI fluorimeter (Photon Technology Instruments, Princeton, NJ). FRET between the tryptophan residues of PKCεC1 and SAPD/dansyl-DAG (Fig.2) and the effect of alcohol on FRET were determined by steady state fluorescence spectroscopy. Briefly, the assay system (1 ml) consisted of buffer (50 mM Tris, 100 mM NaCl and 50 μM ZnSO4, pH 8), 1 μM SAPD, or dansyl-DAG and purified PKCεC1 (4 μM for SAPD and 1μM for DAG). After 60 min incubation at 25 °C, the mixture was excited at 290 nm and emission spectra were recorded from 300 to 550 nm. Fluorescence emission maxima of tryptophan, SAPD, and dansyl-DAG were found to be at 336, 437, and 505 nm, respectively. The relative FRET value was corrected by subtracting the background FRET value following the formula as described earlier [42]: [Fi, +protein − Fi, −protein] − [F0,+protein − F0,−protein], where Fi, +protein and Fi, −protein are the intensities of SAPD or dansyl-DAG in the presence and absence of PKCεC1, respectively, and F0,+protein and F0,−protein are fluorescence intensities of the buffer solution in the presence or absence of PKCεC, respectively. For FRET involving SAPD and dansyl-DAG, intensities at 425 nm and 485 nm, respectively, were recorded. To study the effects of alcohol, increasing concentrations of alcohol were added to the protein and ligand mixture and spectra were recorded after 30 min incubation with slow stirring. The change in fluorescence intensities for each concentration of alcohol was normalized using the equation: (Fi-F0)/F0, where Fi and F0 are intensities of SAPD or dansyl-DAG plus PKCεC1 in the presence or in the absence of alcohol.

2.6. Photoincorpotation of 3-azioctanol and 3-azibutanol into PKCεC1 and identification of the site of photoincorporation by mass spectrometry

Photolabeling experiments were done according to the methods described earlier [32, 43]. Briefly, 50 μl of freshly purified PKCεC1 protein (1μg/ μl) and an azialcohol (1 mM) was incubated for 30 min. Photo-labeling was carried out at 365 nm for 30 min using a model UVL-56 20 W hand-held lamp (Black-Ray, Upland, CA, U.S.A.). Alkylation, reduction by DTT, trypsin digestion, and protein sequencing with LTQ instrument (Thermo-Fisher, San Jose, CA, USA) were done as described earlier [32, 44, 45].

2.7. Molecular modeling

Robetta [46, 47], the structure prediction server which models domains either by homology modeling or by ab initio modeling, was used to predict PKCεC1 domain structure. Sequence of rat PKCεC1 (Fig.1) was used as the input sequence. Robetta modeled the five lowest energy structures on the basis of the structure of homology models using the reference structures with PDB codes 2e73 and 2enZ for C1A and C1B domain, respectively. These two subdomains are connected to each other with a flexible linker. Orientation of C1A and C1B subdomains in the predicted structure with respect to membrane is consistent with a previously reported structure [48, 49], which shows that both the DAG binding domains are on the same face but with varied proximity. The Ramachandran plot showed that all of the residues were within permissible region for all models. Overall quality factor for homology models, such as covalent bond distances, bond angles, stereo chemical validation, atom nomenclature, and non-bonded interactions between different atoms types were validated using SAVS server (http://nihserver.mbi.ucla.edu/SAVES_3). Predicted structure was further energy minimized using Swiss pdb viewer [50].

2.8. Statistical Analysis

Statistical analyses were performed using Sigma Plot 11. Statistical analysis in figures 3 and 6 was based on three independent experiments. The results were expressed as the mean ± SEM. Statistical significance was established using one-way ANOVA, followed by Bonferroni post hoc test. A value of P < 0.05 was considered significant.

Figure 3.

Figure 3

Effect of alcohols and azialocohols on PKCε in NG108-15 cells. Upper panels, Western blot analysis of total cell lysate (A), cytosolic fractions (B), and membrane fraction (C) of PKCε after cells were treated with different alcohols for 24 h. 1) control, 2) 100 mM ethanol, 3) 50 mM butanol, 4) 5 mM 3-azibutanol, 5) 0.5 mM octanol and 6) 0.1 mM 3-azioctanol. Lower panel, corresponding bar graph of densitometry analysis of upper panel immunoblots. Values represent means± SEM of three measurements. Statistical analysis was performed using one-way ANOVA with a post hoc Bonferroni test. * P< 0.05 compared to control; # P<0.05 compared to ethanol; & P<0.05 compared to butanol; $ P<0.001 compared to control and % P< 0.05 compared to ethanol and ** P<0.05 compared to butanol. There were no significant differences in membrane fractions (P>0.05).

Figure 6.

Figure 6

Plot of normalized energy transfer between tryptophan of PKCεC1 and SAPD (▲) or dansyl-DAG (○) in the presence of (A) ethanol; (B) butanol and (C) octanol. Energy transfer efficiency values were calculated using the data from Figure 5 and using the equation described in the methods section. For SAPD (1 μM), protein concentration was 4 μM and for dansyl-DAG (1 μM) the protein concentration was 1μM. Samples were excited at 290 nm. Results are means ± SE from 3 independent experiments. Statistical analysis was performed using one-way ANOVA with a post hoc Bonferroni test. * P< 0.05 and ** P< 0.05 compared to 0 concentration of alcohol.

3. RESULTS

3.1. Effect of alcohol and azialcohol on PKCε in NG108-15 cells

To find out the effect of butanol, octanol, and their diazirine analogs on PKCε, we measured the expression of endogenous PKCε in NG108-15 cells by Western blot analysis of the total cell lysate (Fig. 3A). Incubation of ethanol (100 mM) for 24 h increased the total PKCε expression by 55% compared to control cells. This increase was also observed for butanol and azibutanol. In contrast, octanol and azioctanol decreased the expression by 60-65% compared to untreated cells. We also found a consistent increase in expression of PKCε in the presence of butanol or 3-azibutanol, like ethanol. We also measured the amounts of PKCε in the cytosol (Fig. 3B) and membrane fraction (Fig. 3C) of the alcohol-treated cells. Ethanol and butanol increased and octanol decreased the amounts of PKCε in the cytosol. Overall, the effect of the alcohols on PKCε in the cytosolic fraction was similar to that of the total cell lysate (Fig. 3A). On the other hand, the levels of PKCε in the membrane fractions did not change.

3.2. Protein purification and characterization

The C1 (C1A+C1B) domain of PKCε has been tagged with a His6 at its C-terminus for the purposes of easy purification. This type of modification did not affect the overall folding and ligand property in PKCαC1 as reported earlier [39]. Because of the presence of 13 cysteine residues in this domain that may cause intrinsic instability and insolubility, we decided to characterize the protein thoroughly before using it for alcohol binding studies. The characterization was done by several methods. The purity of the protein was checked by SDS-PAGE and the Coomassie blue staining of the band revealed that the protein was about 95% pure (Figure 4A). The molecular mass was confirmed by MALDI-TOF analysis (Figure 4B), which showed the main peak is at around 15986 Da as expected. In the quantitation experiment of the water-exposed cysteine residues of PKCεC1 with thiol reactive agent aldrithiol-4, it was found that while in the denatured protein about 10 cysteine residues reacted with thiol reactive agent aldrithiol-4 (PDS), no cysteine was reactive in the renatured protein. The presence of these shielded cysteines indicates the folded state of the renatured protein (Fig. 4C). In addition, the fluorescence emission maximum of the renatured PKCεC1 was at 336 nm, the typical emission maximum of a buried tryptophan, again indicating the folded state of the protein (Fig. 5A).

Figure 4.

Figure 4

Characterization of PKCεC1. (A) SDS-PAGE (15%) of the purified PKCεC1. M, molecular weight marker and P, purified PKCεC1. (B) MALDI-TOF mass spectrum of purified PKCεC1. The observed peak at 15986.47 Da matches with the expected molecular mass of the protein. (C) Reaction of PDS with denatured (○) and refolded (▲) PKCεC1. The degree of labeling was presented as the ratio of moles of 4-thiopyridine released to the moles of protein used and plotted as a function of time by measuring the absorbance of 4-thiopyridone at 323 nm, as described in the methods section.

Figure 5.

Figure 5

Effect of alcohol on energy transfer between tryptophan of PKCεC1 and fluorescent PKC ligands SAPD and dansyl-DAG. (A) Emission spectra of a, SAPD (1 μM); b, PKCεC1 (4 μM); c, PKCεC1 (4 μM) + SAPD (1 μM); and d, PKCεC1 (4 μM) + SAPD (1 μM) + butanol (5 mM). (B) Emission spectra of a, dansyl-DAG (1 μM); b, PKCεC1 (1 μM); c, PKCεC1 (1μM) + dansyl-DAG (1μM); and d, PKCεC1 (1μM) + dansyl-DAG (1 μM) + octanol (1 mM). Samples were excited at 290 nm and emission spectra were recorded form 300 nm to 600 nm. Alcohols were incubated for 30 min before the spectra were recorded.

3.3. Effect of alcohol on the fluorescence resonance energy transfer between PKCεC1 and SAPD/dansyl-DAG

For studying energy transfer in PKCεC1, we used two different fluorescent PKC ligands, SAPD (a fluorescent phorbol ester analog) and dansyl-DAG (a fluorescent DAG analog).

The emission maxima of SAPD and dansyl-DAG are 437 nm and 505 nm in buffer, respectively, when excited at 355 nm. In the presence of PKCεC1, these emission maxima shifted to 425 nm and 485 nm, respectively, indicating binding of the fluorophores to the protein. When excited at 290 nm the fluorescence intensities of these two fluorophores at the corresponding emission maxima were much less in the absence of PKCεC1 than the intensities in the presence of PKCεC1 (Fig. 5). This indicates the energy transfer between the tryptophan and the fluorescence ligands, where the former acts as a donor and the latter acts as an acceptor. Next, we measured the effect of alcohol on the FRET between PKCεC1 and these ligands. The effect of butanol (5 mM) on the FRET between PKCεC1 and SAPD and the effect of octanol (1mM) on the FRET between PKCεC1 and dansyl-DAG are shown on Fig. 5A and Fig. 5B, respectively.

The effect of varying concentrations of ethanol, butanol, and octanol for both SAPD and dansyl-DAG is shown in Fig. 6. Overall, with increasing concentrations of either ethanol, butanol, or octanol, the FRET with SAPD increased although the extent of this increment varied among the alcohols studied here. The increase in FRET indicated that with the increasing concentrations of alcohol, there was increased binding of SAPD to the C1B. Similar results were also observed in our previous studies, where alcohols increased the SAPD affinity for truncated δC1B [44] and truncated εC1B [32]. In the case of PKCα, Slater et al also showed that alcohol increased the SAPD binding to the high affinity phorbol site, i.e., αC1B [51]. The changes in FRET between bound SAPD and tryptophan in the presence of alcohol could also be due to the conformational change of the protein caused by alcohol. However, the recent 1.3Å structure of the cyclopropylmethanol-bound δC1B [51] revealed no significant conformational changes between the native and the alcohol-bound structure, thereby reducing this possibility.

Effect of varying concentrations of alcohol on the energy transfer between PKCεC1 and dansyl-DAG was biphasic. At lower concentration range, ethanol (0-65 mM) and octanol (0-1 mM) caused an increase in FRET, but at higher concentration ranges, ethanol (65-130 mM), butanol (13-54 mM) and octanol (1-3 mM) caused decrease in FRET. This decrease in DAG binding in the presence of alcohol indicates that alcohol binding either allosterically or competitively occludes DAG from its binding site.

3.4. Identification of the site of azialcohol photoincorporation in PKCεC1

To identify possible alcohol binding site(s), PKCεC1 was photolabeled with azialcohols 3-azibutanol and 3-azioctanol. After photoincorporation, alkylation, and trypsin digestion, the samples were eluted directly from the online HPLC column into the mass spectrometer, and MS/MS spectra were acquired under automatic acquisition of the most intense ion from each MS scan. About 97% of the peptide sequence for the PKCεC1 was detected by this method. For an unlabeled PKCεC1 sample, the identified peptides, their sequences, charge states, accuracies, and the related peptide match parameter, such as delta correlation (dCn) and X-correlation (XCorr), are listed in Table 1. The collision–activated dissociation MS/MS spectrum of 3-azibutanol modified doubly charged peptide FMATYLR with m/z 487.3, obtained from the digest of 3-azibutanol (1mM)–labeled PKCεC1, is shown in Fig. 7A. All the b ions except the b1 were detected and b5-b7 had extra mass of 72 Da indicating modification at position 5. In the y ion series all the ions were detected and y3-y7 had extra mass of 72 Da. This confirmed that the tyrosine at position 5 (Tyr-176 in the full length protein) in the peptide is modified with azibutanol. The delta correlation (dCn) and the cross correlation (XCorr) values for this peptide are 0.236 and 2.8, respectively. The unmodified peptide with the m/z of 451.2 was also detected. In the 3-azibutanol photolabeled sample, the peptide FGIHNYK was also found to be labeled. Fig. 7B shows the collision–activated dissociation MS/MS spectrum of the doubly charged peptide ion with m/z 476.3 for the peptide FGIHNYK. In the b ion series, b1 through b6 were observed of which b6 ion has the extra mass of 72 Da for the addition of a molecule of 3-aziobutanol. In the y ion series, y2-y5 were observed and have extra mass of 72 Da for the addition of one molecule 3-azibutanol. Although the y6 was not observed, the y6++ at 402.4 was very distinct in the MS/MS spectrum. Another doubly charged fragment ion y5++ was also observed at m/z 374. This indicates that position 6 of the peptide is the site of modification which is Tyr-250 of the full length PKCε. The unmodified doubly charged peptide was detected at m/z of 440 having all the assigned b and y ions.

Table 1.

Identification of the PKCε C1 tryptic peptidesa by LTQ-FT mass spectrometry

Positionb Sequence Charge state Predicted
massc
Observed
massc
Accuracyd
(ppm)
dCn XCorr
172-178 FMATYLR 2 451.231962 451.233658 3.15 .7835 1.81
179-187 QPTYCSHCR 3 403.503095 403.502698 1.44 .4370 1.59
179-196 QPTYCSHCRDFIWGVIGK 3 742.018752 742.019065 .18 .503 2.46
188-196 DFIWGVIGK 2 517.787319 517.787111 .94 .753 2.71
197-210 QGYQCQVCTCVVHK 3 589.596590 589.597221 .76 .495 3.36
197-211 QGYQCQVCTCVVHKR 3 641.631665 641.630925 1.44 .54 3.91
211-219 RCHELIITK 3 390.553295 390.553498 .05 .556 4.09
212-219 CHELIITK 2 478.764124 478.765321 1.92 .618 2.42
220-224 CAGLK 1 548.285830 548.286096 .53 .625 1.12
220-225 CAGLKK 1 676.382810 676.381059 3.40 .405 1.48
225-236 KQETPDEVGSQR 3 458.559339 458.560035 1.12 .613 3.79
212-236 CHELIITKCAGLKKQET
PDEVGSQR
3 966.491673 966.491781 .08 .498 6.21
220-236 CAGLKKQETPDEVGSQR 2 951.970914 951.970539 .68 .772 5.31
226-236 QETPDEVGSQR 2 623.288414 623.288932 .39 .636 2.17
237-244 FSVNMPHK 2 480.241754 480.242014 .03 .766 2.5
237-251 FSVNMPHKFGIHNYK 3 606.974135 606.975126 1.33 .538 3.31
245-251 FGIHNYK 2 439.729484 439.729597 .38 .747 2.77
252-268 VPTFCDHCGSLLWGLLR 3 677.670302 677.669485 1.48 .569 4.57
269-274 QGLQCK 1 733.366760 733.366137 1.60 .708 1.21
269-277 QGLQCKVCK 2 560.783289 560.783720 .28 .552 1.22
269-282 QGLQCKVCKMNVHR 3 586.628432 586.628855 .41 .613 3.84
278-282 MNVHR 1 656.330200 656.329692 1.62 .707 .99
278-283 MNVHRR 2 406.719324 406.719040 1.38 .728 1.63
275-283 VCKMNVHRR 3 400.546492 400.546461 .53 .52 1.60
269-283 QGLQCKVCKMNVHRR 4 479.248176 479.248739 .89 .535 3.07
284-292 CETNVAPNCGLEHHHHHH 3 729.310397 729.309901 .93 .620 3.80
a

The protein was digested with trypsin and infused into the mass spectrometer.

b

Numbering is according to the position of the peptides in the full-length PKCε as shown in Figure 1.

c

Monoisotopic mass that includes iodoacetamide modified (additional mass of 57 Da) cysteines.

d

Accuracy is the fractional difference between the predicted and observed mass expressed in ppm.

dCn and Xcorr represents delta correlation and cross correlation respectively.

Figure 7.

Figure 7

MS/MS data for the photolabeled peptides. At the top of the figure the predicted m/z ratio of N-terminal ions (b ions) and C-terminal ions (y ions) are shown above and below the sequence, respectively. They are singly charged unless noted otherwise. The horizontal arrows show which m/z values for the b ions (above) and y ions (below) have a mass of 72 Da for 3-azibutanol or 128 Da for 3-azioctanol added to them. Observed values are shown in bold. (A) Identification of the Tyr-176 as the site for 3-azioctanol in the PKCεC1 domain. MS/MS data for the 3-azibutanol (1 mM) modified heptamer peptide FMATYLR. The delta correlation (dCn) and the cross correlation (XCorr) values for this peptide are 0.226 and 2.2, respectively. (B) Identification of the Tyr-250 as the site for 3-azibutanol in the PKCεC1 domain. MS/MS data for the 3-azibutanol (1 mM) modified heptamer peptide FGIHNYK. In addition to the singly charged ions, a doubly charged y5++ (m/z 374) and y6++(m/z 402.4) ion is also observed. The delta correlation (dCn) and the cross correlation (XCorr) values for this peptide are 0.128 and 2.4, respectively. (C) Identification of the Tyr-176 as the site for 3-azioctanol in the PKCε C1 domain. MS/MS data for the 3-azioctanol (1 mM) modified heptamer peptide FMATYLR. The delta correlation (dCn) and the cross correlation (XCorr) values for this peptide are 0.226 and 2.2, respectively.

In the 3-azioctanol (1mM) photolabeled sample, the same doubly charged heptamer peptide FMATYLR at m/z 515.3 was found to be modified (Fig. 7C). In this case all the b ions except the b1 were detected and b5-b7 have extra mass of 128 Da indicating 3-azioctanol modification. In the y ion series all the ions from y1 to y7 were detected and the y3 through y7 were found to be modified. This indicated that tyrosine at position 5 is the site of modification. In this case, the unmodified peptide also has been detected and showed similar fragmentation pattern. In this digest, another peptide FSVNMPHKFGIHNYK corresponding to the C1B subdomain was also found to be modified with 3-azioctanol (XCorr, 2.08; dCn, 0.04). However, the exact site of modification could not be assigned because only 22 of the 84 possible fragment ions were observed in the MS/MS spectrum.

In summary, the photolabeling experiments identified Tyr-176 in the C1A and Tyr-250 in the C1B subdomain of PKCε.

4. DISCUSSION

Regulation of alcohol action by PKC, especially PKCε, is well studied [2, 23, 24] although the mechanism of this regulation is still not well-established. We hypothesized that alcohol molecules directly interact with PKCε and identified an alcohol binding site in the C1B subdomain of PKCε. In view of the observation by Slater et al that in PKCα, alcohol binding sites are present in both C1A and C1B [51], we asked the question whether such alcohol binding sites could also be present in PKCε. To address this we expressed and purified the C1(combined C1A and C1B) domain of PKCε and studied its interactions with alcohols. PKC is a complex kinase which is active when tightly associated with the membrane (hence limited solubility) and susceptible to proteolysis when activated. PKC also undergoes massive conformational changes during its activation. To circumvent these issues we decided to study the truncated C1 domain of PKCε for pinpointing the alcohol binding sites. Such a piecemeal approach is not uncommon in studying alcohol-protein interactions [52] [43]. The C1 domains of PKC possess a highly conserved structure that retains all the structural elements whether studied in isolation [53] or in the full length protein [54]. For example, binding affinity of PDBu (phorbol-12, 13 dibutyrate) to PKCεC1B (Kd =1.5 nM) and full-length PKCε (Kd =0.63 nM) are not significantly different [55].

Our results show that azialcohols behave similarly to their precursor alcohols on the expression of PKCε in NG108-15 cells (Fig. 3). Ethanol, butanol and azibutanol increased expression of PKCε in a manner similar to what was reported earlier for ethanol (200 mM, 48h) by Gordon et al [29]. This data for ethanol is consistent with cytoplasmic increases as noted by Gordon et al.[29]. This is likely indicative of transcription/translation effects. Decrease in protein expression by octanol and 3-azioctanol could be due to octanol-induced cell death [56] as we observed that a significant number of cells were not viable and were detached from the plates when the octanol concentration was higher than 1 mM. Other possibilities could be the inhibition of cell adhesion and/or alcohol-dependent cell apoptosis at higher alcohol concentrations [57]. Another objective of this study was to find out if alcohol and azialcohol could induce translocation of PKCε from cytosol to other cellular compartments. The results shown in Fig.3 demonstrated that there was no change in the PKCε in the membrane fraction, suggesting that there was no significant translocation occurred from cytosol to plasma membrane. However, this does not rule out the possibility of translocation of PKCε to the perinuclear region, which the present study could not resolve. Previous studies on the effect of ethanol on PKCε in cells and brain tissues suggested that alcohol-induced increase of PKCε in cytosol was a combination of both increased expression and translocation to the membrane or perinuclear region [29, 58].

There are few discrepancies in the literature on the magnitude of the DAG/phorbol ester affinity for the C1A and the C1B subdomains of PKCε. For example, whereas Irie et al first reported much higher affinity of εC1B (Kd =1.5 nM) than εC1A (Kd > 10000 nM) for phorbol ester [55], Stahelin et al reported only 3 times higher affinity for εC1B than εC1A [59]. In another publication, Irie et al. reported only 7 times higher phorbol ester affinity for εC1B (Kd =0.81 nM) than εC1A (Kd =5.6 nM) [60]. For DAG, εC1A binds to DiC18 (a DAG analog) with about five times higher affinity than εC1B [59]. Taken together, the εC1B has higher affinity than εC1A for phorbol ester and εC1A has higher affinity than εC1B for DAG. That SAPD (a phorbol ester) and dansyl-DAG (a DAG analog) have different affinities for C1A and C1B, and show different FRET sensitivities for different alcohols, it is logical to conclude that alcohols exert differential effects on C1A and C1B subdomains of PKCε.

In addition to the fluorescent phorbol ester SAPD, which was used previously for studying the C1B subdomain [32], here we introduced a new fluorescent DAG analog, dansyl-DAG. The present result is closely similar to the previous results involving the isolated C1B subdomain in that ethanol, butanol, and octanol increased the SAPD binding to the C1B subdomain and the azialcohol labeled the protein in the vicinity of His-248 and Tyr-250. The only difference is that in the photolabeling experiment, we did not detect the His-248 unambiguously, although a peptide, FSVNMPHKFGIHNYK, containing this residue was photolabeled. This is most likely due to the presence of the linker and C1A subdomain which fine-tunes the access of this residue to the photo reagents and/or the protease trypsin. In addition to the Tyr-250 in C1B we identified another site Tyr-176 in the C1A. The photoincorporation of the tyrosine residues in both C1A and C1B subdomains of PKCε photolabeling cannot be viewed as azialcohols being solely tyrosine-selective agents because azialcohols react with variety of amino acids [34, 43] and other tyrosine residues (Tyr-182 and Tyr-199) in the C1 domain were not labeled. Interestingly, the double dissociative effects of n-chain alcohols on phorbol/DAG binding closely resembles to the recent in vivo data reported by the Morrow group where DAG-dependent PKCε activity was evident at moderate alcohol doses [58], but completely absent at higher doses [61]. However, more studies are required to establish direct correlation between the in vitro binding and the in vivo data.

The modeled structure of the C1 domain indicates that the distance between the photolabeled residues, Tyr-176 and Tyr-250 (Cβ of Tyr-176 and Cβ of Tyr-250) is 40.07Å, (Fig. 8) meaning that these residues may not be part of a single alcohol binding site but most likely form two different alcohol binding sites, one in the C1A and the other in the C1B. In the C1A, the Trp-191 (involved in FRET) and Tyr-176 are 10.38 Å apart from each other and both are located close (3-5 Å) to the ligand binding site of C1A, indicating that binding of alcohol molecules in the vicinity of Tyr-176 could influence the energy transfer between dansyl-DAG and Trp-191. The structure also reveals that the side chain of Tyr-176 and Trp-191 are oriented in the same direction forming a well-defined binding site in which both butanol and octanol could fit. Leu-177, Arg-178, Gln-179, and Gln-197 also contribute to the formation of this binding site. In the C1B, the photolabeled residue Tyr-250 is located 13.25 Å from Trp-264 (involved in FRET) and both are located about 5-7 Å from the ligand binding site of C1B. However, their side chains are oriented opposite to one another indicating that Trp-264 may not contribute to the formation of the binding site. His-248, Val-252, Thr-254, and Gln-272 are close to Tyr-250 and form the putative alcohol binding site in C1B. While it is not clear whether these differences in orientation could affect the alcohol binding of these domains, this will certainly affect their membrane affinity [59].

Figure 8.

Figure 8

Location of alcohol binding residues in PKCεC1 structure. Surface diagram of PKCεC1 showing the alcohol-binding tyrosine residues. 3-azialcohol labeled residues (Y176 and Y250) and the tryptophan residues that are involved in FRET with SAPD and dansyl-DAG are shown in red and blue respectively. The linker region between C1A and C1B is shown in purple. Molecular-graphics images were produced by using the UCSF Chimera package from the Computer Graphics Laboratory, University of California San Francisco, San Francisco, CA, U.S.A.

A comparison of the alcohol binding site residues of PKCδ, PKCα, and PKCε from the available literature data reveals that, like PKCδ and PKCα, PKCε has alcohol binding sites in the C1A and the C1B domains. While the alcohol binding residues have not been determined for the αC1A, the alcohol binding residue in the δC1A is Tyr-187, which is homologous to Tyr-199 of PKCε. Tyr-199 is 11.18 Å apart from Tyr-176 and orientation of their side chains is in opposite directions, indicating that they perhaps do not belong to the same alcohol binding site. On the other hand the Tyr-236 of δC1B, which is homologous to His-248 of PKCε, is close to Tyr-250, the site identified in this study. These data indicate that the alcohol-binding site for δC1A and εC1A are different, but could be similar for δC1B εC1B. Furthermore, the residues present within 3 Å of the alcohol binding residues of C1A and C1B are different. Interestingly, our recent 1.3 Å data for the PKCδC1B-cyclopropylmethanol revealed that the Tyr-236, homologous to His-248 in epsilon, formed a hydrogen bond (2.8-3 Å) with the hydroxyl group of the alcohol and the methylene group of Met-239, homologous to Lys-251 in PKCε, which undergoes van der Waals interactions with the cyclopropane ring of the alcohol [52]. The homologous residues in PKCα and PKCε isoforms are different (Fig.9). All of these indicated that the microenvironments of the alcohol binding sites in C1A and C1B are different for different PKC isoforms.

Figure 9.

Figure 9

Comparison of the primary sequences of the C1A and C1B subdomains of PKCα, PKCδ, and PKCε. The photolabeled residues are boxed.

Our results that alcohol regulates the activity of PKCε [32] and binds to it, validate it as a potential target of alcohol, as regulation and binding are two of the four criteria suggested by Harris et al [62] for a protein to be considered as a target of alcohol, and underscore the importance of this PKC isoform in developing an alcohol antagonist.

Highlights.

  • Alcohol and azialcohol affect PKCε expression in NG108-15 cells

  • Alcohols bind to both C1A and C1B subdomains of PKCε

  • Azialcohols photolabel Tyr-176 in C1A and Tyr-250 in C1B of PKCε

ACKNOWLEDGEMENTS

Dr. M. D. Best of the Department of Chemistry, The University of Tennessee, Knoxville, Tennessee for providing the dansyl-DAG. This research is supported by the NIAAA/NIH grant 1R21AA016140 to JD.

Abbreviations

PKC

protein kinase C

FRET

fluorescence resonance energy transfer

DAG

sn-1,2-diacylglycerol

HRP

horseradish peroxidase

LC–MS/MS

liquid chromatography/ tandem MS

PDB

Protein Data Bank

POPC

1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine

POPS

1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine

SAPD

sapintoxin-D

dansyl-DAG

(2S,3S)-1-(4-((5-(dimethylamino)naphthalene-1-sulfonamido)methyl)-1H-1,2,3-triazol-1-yl)-4-hydroxybutane-2,3-diyl distearate

GABA

gamma amino butyric acid

SDS-PAGE

sodium dodecyl sulfonate-polyacrylamide gel electrophoresis

MALDI-TOF

matrix-assisted laser-desorption ionization–time-of-flight

WT

wild-type

PBS

phosphate buffered saline

RACK

receptor for activated C-kinase

DiC18

sn-1,2-dioleoylglycerol

PDBu

phorbol 12,13-dibutyrate

Footnotes

The authors have no conflict of interests.

AUTHOR CONTRIBUTION

Joydip Das designed the research. Joydip Das and Satyabrata Pany performed the research, analyzed the data, and wrote the paper.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

REFERENCES

  • [1].Shirai Y, Adachi N, Saito N. Protein kinase Cepsilon: function in neurons. The FEBS J. 2008;275:3988–3994. doi: 10.1111/j.1742-4658.2008.06556.x. [DOI] [PubMed] [Google Scholar]
  • [2].Newton PM, Ron D. Protein kinase C and alcohol addiction. Pharmacol. Res. 2007;55:570–577. doi: 10.1016/j.phrs.2007.04.008. [DOI] [PubMed] [Google Scholar]
  • [3].Stubbs CD, Slater SJ. Ethanol and protein kinase C. Alcohol. Clin. Exp. Res. 1999;23:1552–1560. [PubMed] [Google Scholar]
  • [4].Olive MF, Messing RO. Protein kinase C isozymes and addiction. Mol. Neurobiol. 2004;29:139–154. doi: 10.1385/mn:29:2:139. [DOI] [PubMed] [Google Scholar]
  • [5].Lee AM, Messing RO. Protein kinases and addiction. Ann. N. Y. Acad. Sci. 2008;1141:22–57. doi: 10.1196/annals.1441.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [6].Cho W. Membrane targeting by C1 and C2 domains. J. Biol. Chem. 2001;276:32407–32410. doi: 10.1074/jbc.R100007200. [DOI] [PubMed] [Google Scholar]
  • [7].Newton AC. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem. Rev. 2001;101:2353–2364. doi: 10.1021/cr0002801. [DOI] [PubMed] [Google Scholar]
  • [8].Corbalan-Garcia S, Gomez-Fernandez JC. Protein kinase C regulatory domains: the art of decoding many different signals in membranes. Biochim. Biophys. Acta. 2006;1761:633–654. doi: 10.1016/j.bbalip.2006.04.015. [DOI] [PubMed] [Google Scholar]
  • [9].Tanaka C, Nishizuka Y. The protein kinase C family for neuronal signaling. Annu. Rev. Neurosci. 1994;17:551–567. doi: 10.1146/annurev.ne.17.030194.003003. [DOI] [PubMed] [Google Scholar]
  • [10].Nili U, de Wit H, Gulyas-Kovacs A, Toonen RF, Sorensen JB, Verhage M, Ashery U. Munc18-1 phosphorylation by protein kinase C potentiates vesicle pool replenishment in bovine chromaffin cells. Neuroscience. 2006;143:487–500. doi: 10.1016/j.neuroscience.2006.08.014. [DOI] [PubMed] [Google Scholar]
  • [11].Lanuza MA, Santafe MM, Garcia N, Besalduch N, Tomas M, Obis T, Priego M, Nelson PG, Tomas J. Protein kinase C isoforms at the neuromuscular junction: localization and specific roles in neurotransmission and development. J. Anat. 2014;224:61–73. doi: 10.1111/joa.12106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [12].Kazanietz MG, Wang S, Milne GW, Lewin NE, Liu HL, Blumberg PM. Residues in the second cysteine-rich region of protein kinase C delta relevant to phorbol ester binding as revealed by site-directed mutagenesis. J. Biol. Chem. 1995;270:21852–21859. doi: 10.1074/jbc.270.37.21852. [DOI] [PubMed] [Google Scholar]
  • [13].Szallasi Z, Bogi K, Gohari S, Biro T, Acs P, Blumberg PM. Non-equivalent roles for the first and second zinc fingers of protein kinase Cdelta. Effect of their mutation on phorbol ester-induced translocation in NIH 3T3 cells. J. Biol. Chem. 1996;271:18299–18301. doi: 10.1074/jbc.271.31.18299. [DOI] [PubMed] [Google Scholar]
  • [14].Slater SJ, Ho C, Kelly MB, Larkin JD, Taddeo FJ, Yeager MD, Stubbs CD. Protein kinase Calpha contains two activator binding sites that bind phorbol esters and diacylglycerols with opposite affinities. J. Biol. Chem. 1996;271:4627–4631. doi: 10.1074/jbc.271.9.4627. [DOI] [PubMed] [Google Scholar]
  • [15].Medkova M, Cho W. Interplay of C1 and C2 domains of protein kinase C-alpha in its membrane binding and activation. J. Biol. Chem. 1999;274:19852–19861. doi: 10.1074/jbc.274.28.19852. [DOI] [PubMed] [Google Scholar]
  • [16].Mochly-Rosen D. Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science. 1995;268:247–251. doi: 10.1126/science.7716516. [DOI] [PubMed] [Google Scholar]
  • [17].Schechtman D, Mochly-Rosen D. Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene. 2001;20:6339–6347. doi: 10.1038/sj.onc.1204778. [DOI] [PubMed] [Google Scholar]
  • [18].Ali AS, Ali S, El-Rayes BF, Philip PA, Sarkar FH. Exploitation of protein kinase C: a useful target for cancer therapy. Cancer Treat. Rev. 2009;35:1–8. doi: 10.1016/j.ctrv.2008.07.006. [DOI] [PubMed] [Google Scholar]
  • [19].Hodge CW, Mehmert KK, Kelley SP, McMahon T, Haywood A, Olive MF, Wang D, Sanchez-Perez AM, Messing RO. Supersensitivity to allosteric GABA(A) receptor modulators and alcohol in mice lacking PKCepsilon. Nat. Neurosci. 1999;2:997–1002. doi: 10.1038/14795. [DOI] [PubMed] [Google Scholar]
  • [20].Olive MF, Mehmert KK, Messing RO, Hodge CW. Reduced operant ethanol self-administration and in vivo mesolimbic dopamine responses to ethanol in PKCepsilon-deficient mice. Eur. J. Neurosci. 2000;12:4131–4140. doi: 10.1046/j.1460-9568.2000.00297.x. [DOI] [PubMed] [Google Scholar]
  • [21].Bowers BJ, Wehner JM. Ethanol consumption and behavioral impulsivity are increased in protein kinase Cgamma null mutant mice. J. Neurosci. 2001;21:RC180. doi: 10.1523/JNEUROSCI.21-21-j0004.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [22].Harris RA, McQuilkin SJ, Paylor R, Abeliovich A, Tonegawa S, Wehner JM. Mutant mice lacking the gamma isoform of protein kinase C show decreased behavioral actions of ethanol and altered function of gamma-aminobutyrate type A receptors. Proc. Natl. Acad. Sci. U.S.A. 1995;92:3658–3662. doi: 10.1073/pnas.92.9.3658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [23].Lesscher HM, Wallace MJ, Zeng L, Wang V, Deitchman JK, McMahon T, Messing RO, Newton PM. Amygdala protein kinase C epsilon controls alcohol consumption. Genes Brain Behav. 2009;8:493–499. doi: 10.1111/j.1601-183X.2009.00485.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [24].Choi DS, Wang D, Dadgar J, Chang WS, Messing RO. Conditional rescue of protein kinase C epsilon regulates ethanol preference and hypnotic sensitivity in adult mice. J. Neurosci. 2002;22:9905–9911. doi: 10.1523/JNEUROSCI.22-22-09905.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [25].McMahon T, Andersen R, Metten P, Crabbe JC, Messing RO. Protein kinase C epsilon mediates up-regulation of N-type calcium channels by ethanol. Mol. Pharmacol. 2000;57:53–58. [PubMed] [Google Scholar]
  • [26].Shumilla JA, Liron T, Mochly-Rosen D, Kendig JJ, Sweitzer SM. Ethanol withdrawal-associated allodynia and hyperalgesia: age-dependent regulation by protein kinase C epsilon and gamma isoenzymes. J. Pain. 2005;6:535–549. doi: 10.1016/j.jpain.2005.03.005. [DOI] [PubMed] [Google Scholar]
  • [27].Hundle B, McMahon T, Dadgar J, Chen CH, Mochly-Rosen D, Messing RO. An inhibitory fragment derived from protein kinase Cepsilon prevents enhancement of nerve growth factor responses by ethanol and phorbol esters. J. Biol. Chem. 1997;272:15028–15035. doi: 10.1074/jbc.272.23.15028. [DOI] [PubMed] [Google Scholar]
  • [28].Virmani M, Ahluwalia B. Biphasic protein kinase C translocation in PC12 cells in response to short-term and long-term ethanol exposure. Alcohol Alcohol. 1992;27:393–401. [PubMed] [Google Scholar]
  • [29].Gordon AS, Yao L, Wu ZL, Coe IR, Diamond I. Ethanol alters the subcellular localization of delta- and epsilon protein kinase C in NG108-15 cells. Mol. Pharmacol. 1997;52:554–559. doi: 10.1124/mol.52.4.554. [DOI] [PubMed] [Google Scholar]
  • [30].Yao L, Fan P, Jiang Z, Gordon A, Mochly-Rosen D, Diamond I. Dopamine and ethanol cause translocation of epsilonPKC associated with epsilonRACK: cross-talk between cAMP-dependent protein kinase A and protein kinase C signaling pathways. Mol. Pharmacol. 2008;73:1105–1112. doi: 10.1124/mol.107.042580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [31].Gordon AS, Yao L, Jiang Z, Fishburn CS, Fuchs S, Diamond I. Ethanol acts synergistically with a D2 dopamine agonist to cause translocation of protein kinase C. Mol. Pharmacol. 2001;59:153–160. doi: 10.1124/mol.59.1.153. [DOI] [PubMed] [Google Scholar]
  • [32].Das J, Pany S, Rahman GM, Slater SJ. PKC epsilon has an alcohol-binding site in its second cysteine-rich regulatory domain. Biochem. J. 2009;421:405–413. doi: 10.1042/BJ20082271. [DOI] [PubMed] [Google Scholar]
  • [33].Gable RS. Comparison of acute lethal toxicity of commonly abused psychoactive substances. Addiction. 2004;99:686–696. doi: 10.1111/j.1360-0443.2004.00744.x. [DOI] [PubMed] [Google Scholar]
  • [34].Das J. Aliphatic diazirines as photoaffinity probes for proteins: recent developments. Chem. Rev. 2011;111:4405–4417. doi: 10.1021/cr1002722. [DOI] [PubMed] [Google Scholar]
  • [35].Husain SS, Forman SA, Kloczewiak MA, Addona GH, Olsen RW, Pratt MB, Cohen JB, Miller KW. Synthesis and properties of 3-(2-hydroxyethyl)-3-n-pentyldiazirine, a photoactivable general anesthetic. J. Med. Chem. 1999;42:3300–3307. doi: 10.1021/jm9806300. [DOI] [PubMed] [Google Scholar]
  • [36].Church RFR, Weiss MJ. Diazirines. II. Synthesis and properties of small functionalized diazirine molecules. Some observations on the reaction of a diazirine with the iodine-iodide ion system. J. Org. Chem. 1970;35:2465–2471. [Google Scholar]
  • [37].Luo J, Miller MW. Differential sensitivity of human neuroblastoma cell lines to ethanol: correlations with their proliferative responses to mitogenic growth factors and expression of growth factor receptors. Alcohol. Clin. Exp. Res. 1997;21:1186–1194. [PubMed] [Google Scholar]
  • [38].Ha CE, Petersen CE, Park DS, Harohalli K, Bhagavan NV. Investigations of the effects of ethanol on warfarin binding to human serum albumin. J. Biomed. Sci. 2000;7:114–121. doi: 10.1007/BF02256617. [DOI] [PubMed] [Google Scholar]
  • [39].Cho W, Digman M, Ananthanarayanan B, Stahelin RV. Bacterial expression and purification of C1 and C2 domains of protein kinase C isoforms. Methods Mol. Biol. 2003;233:291–298. doi: 10.1385/1-59259-397-6:291. [DOI] [PubMed] [Google Scholar]
  • [40].Klein-Seetharaman J, Hwa J, Cai K, Altenbach C, Hubbell WL, Khorana HG. Single-cysteine substitution mutants at amino acid positions 55-75, the sequence connecting the cytoplasmic ends of helices I and II in rhodopsin: reactivity of the sulfhydryl groups and their derivatives identifies a tertiary structure that changes upon light-activation. Biochemistry. 1999;38:7938–7944. doi: 10.1021/bi990013t. [DOI] [PubMed] [Google Scholar]
  • [41].Cai K, Klein-Seetharaman J, Farrens D, Zhang C, Altenbach C, Hubbell WL, Khorana HG. Single-cysteine substitution mutants at amino acid positions 306-321 in rhodopsin, the sequence between the cytoplasmic end of helix VII and the palmitoylation sites: sulfhydryl reactivity and transducin activation reveal a tertiary structure. Biochemistry. 1999;38:7925–7930. doi: 10.1021/bi9900119. [DOI] [PubMed] [Google Scholar]
  • [42].Slater SJ, Taddeo FJ, Mazurek A, Stagliano BA, Milano SK, Kelly MB, Ho C, Stubbs CD. Inhibition of membrane lipid-independent protein kinase Calpha activity by phorbol esters, diacylglycerols, and bryostatin-1. J. Biol. Chem. 1998;273:23160–23168. doi: 10.1074/jbc.273.36.23160. [DOI] [PubMed] [Google Scholar]
  • [43].Das J, Xu S, Pany S, Guillory A, Shah V, Roman GW. The pre-synaptic Munc13-1 binds alcohol and modulates alcohol self-administration in Drosophila. J. Neurochem. 2013;126:715–726. doi: 10.1111/jnc.12315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [44].Das J, Addona GH, Sandberg WS, Husain SS, Stehle T, Miller KW. Identification of a general anesthetic binding site in the diacylglycerol-binding domain of protein kinase Cdelta. J. Biol. Chem. 2004;279:37964–37972. doi: 10.1074/jbc.M405137200. [DOI] [PubMed] [Google Scholar]
  • [45].Das J, Zhou X, Miller KW. Identification of an alcohol binding site in the first cysteine-rich domain of protein kinase Cdelta. Protein Sci. 2006;15:2107–2119. doi: 10.1110/ps.062237606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [46].Kim DE, Chivian D, Baker D. Protein structure prediction and analysis using the Robetta server. Nucleic Acids Res. 2004;32:W526–531. doi: 10.1093/nar/gkh468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [47].Richardson TG, Thomas EC, Sessions RB, Lawlor DA, Tavare JM, Day IN. Structural and population-based evaluations of TBC1D1 p.Arg125Trp. PloS one. 2013;8:e63897. doi: 10.1371/journal.pone.0063897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [48].Srinivasan N, Bax B, Blundell TL, Parker PJ. Structural aspects of the functional modules in human protein kinase-C alpha deduced from comparative analyses. Proteins. 1996;26:217–235. doi: 10.1002/(SICI)1097-0134(199610)26:2<217::AID-PROT11>3.0.CO;2-S. [DOI] [PubMed] [Google Scholar]
  • [49].Giorgione J, Hysell M, Harvey DF, Newton AC. Contribution of the C1A and C1B domains to the membrane interaction of protein kinase C. Biochemistry. 2003;42:11194–11202. doi: 10.1021/bi0350046. [DOI] [PubMed] [Google Scholar]
  • [50].Schwede T, Kopp J, Guex N, Peitsch MC. SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res. 2003;31:3381–3385. doi: 10.1093/nar/gkg520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [51].Slater SJ, Kelly MB, Larkin JD, Ho C, Mazurek A, Taddeo FJ, Yeager MD, Stubbs CD. Interaction of alcohols and anesthetics with protein kinase Calpha. J. Biol. Chem. 1997;272:6167–6173. doi: 10.1074/jbc.272.10.6167. [DOI] [PubMed] [Google Scholar]
  • [52].Shanmugasundararaj S, Das J, Sandberg WS, Zhou X, Wang D, Messing RO, Bruzik KS, Stehle T, Miller KW. Structural and functional characterization of an anesthetic binding site in the second cysteine-rich domain of protein kinase Cdelta. Biophys. J. 2012;103:2331–2340. doi: 10.1016/j.bpj.2012.10.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [53].Zhang G, Kazanietz MG, Blumberg PM, Hurley JH. Crystal structure of the cys2 activator-binding domain of protein kinase C delta in complex with phorbol ester. Cell. 1995;81:917–924. doi: 10.1016/0092-8674(95)90011-x. [DOI] [PubMed] [Google Scholar]
  • [54].Leonard TA, Rozycki B, Saidi LF, Hummer G, Hurley JH. Crystal structure and allosteric activation of protein kinase C betaII. Cell. 2011;144:55–66. doi: 10.1016/j.cell.2010.12.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [55].Irie K, Oie K, Nakahara A, Yanai Y, Ohigashi H, Wender PA, Fukuda H, Konishi H, Kikkawa U. Molecular basis for Protein Kinase C isozyme-selective binding: the systhesis, folding, and phorbol ester binding of the cysteine-rich domains of all Protein Kinase C isozymes. J. Am. Chem. Soc. 1998;120:9159–9167. [Google Scholar]
  • [56].Wilkemeyer MF, Menkari CE, Spong CY, Charness ME. Peptide antagonists of ethanol inhibition of l1-mediated cell-cell adhesion. J. Pharmacol. Exp. Ther. 2002;303:110–116. doi: 10.1124/jpet.102.036277. [DOI] [PubMed] [Google Scholar]
  • [57].Chen SY, Wilkemeyer MF, Sulik KK, Charness ME. Octanol antagonism of ethanol teratogenesis. FASEB J. 2001;15:1649–1651. doi: 10.1096/fj.00-0862fje. [DOI] [PubMed] [Google Scholar]
  • [58].Kumar S, Lane BM, Morrow AL. Differential effects of systemic ethanol administration on protein kinase cepsilon, gamma, and beta isoform expression, membrane translocation, and target phosphorylation: reversal by chronic ethanol exposure. J. Pharmacol. Exp. Ther. 2006;319:1366–1375. doi: 10.1124/jpet.106.110890. [DOI] [PubMed] [Google Scholar]
  • [59].Stahelin RV, Digman MA, Medkova M, Ananthanarayanan B, Melowic HR, Rafter JD, Cho W. Diacylglycerol-induced membrane targeting and activation of protein kinase Cepsilon: mechanistic differences between protein kinases Cdelta and Cepsilon. J. Biol. Chem. 2005;280:19784–19793. doi: 10.1074/jbc.M411285200. [DOI] [PubMed] [Google Scholar]
  • [60].Irie K, Nakahara A, Nakagawa Y, Ohigashi H, Shindo M, Fukuda H, Konishi H, Kikkawa U, Kashiwagi K, Saito N. Establishment of a binding assay for protein kinase C isozymes using synthetic C1 peptides and development of new medicinal leads with protein kinase C isozyme and C1 domain selectivity. Pharmacol. Ther. 2002;93:271–281. doi: 10.1016/s0163-7258(02)00196-1. [DOI] [PubMed] [Google Scholar]
  • [61].Kumar S, Ren Q, Beckley JH, O’Buckley TK, Gigante ED, Santerre JL, Werner DF, Morrow AL. Ethanol Activation of Protein Kinase A Regulates GABA(A) Receptor Subunit Expression in the Cerebral Cortex and Contributes to Ethanol-Induced Hypnosis. Front. Neurosci. 2012;6:44. doi: 10.3389/fnins.2012.00044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [62].Harris RA, Trudell JR, Mihic SJ. Ethanol’s molecular targets. Science Signal. 2008;1:re7. doi: 10.1126/scisignal.128re7. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES